Re: efavirenz pbpk input parameters

From: Masoud Jamei Date: July 01, 2013 technical Source: mail-archive.com
Hi Bernard Please see the following two papers and if you search Pubmed you may find more. Rekic D, Roshammar D, Mukonzo J, and Ashton M (2011) In silico prediction of efavirenz and rifampicin drug-drug interaction considering weight and CYP2B6 phenotype. *Br J Clin Pharmacol* *71:*536-543. Siccardi M, Marzolini C, Seden K, Almond L, Kirov A, Khoo S, Owen A, and Back D (2013) Prediction of drug-drug Interactions Between Various Antidepressants and Efavirenz or Boosted Protease Inhibitors Using a Physiologically Based Pharmacokinetic Modelling Approach. *Clin Pharmacokinet* *52:*583-592. Regards Masoud
Quoted reply history
On 1 July 2013 14:52, Bernard Ngara <[email protected]> wrote: > Dear user > > I am learning modelling and simulation of the efavirenz compound using > the In Silico PBPK approach. May you please assist with information on > literature where i can obtain input a variety of model input > parameters. > > Thank you > > Bernard > > BernardNgara > Trainee Biostatistician > Africa Institute of Biomedical Science and Technology > P. O Box 2294 > Harare > Zimbabwe > +263 772 160 896 >
Jul 01, 2013 Bernard Ngara efavirenz pbpk input parameters
Jul 01, 2013 Dinko Rekic RE: efavirenz pbpk input parameters
Jul 01, 2013 Masoud Jamei Re: efavirenz pbpk input parameters